Strata Oncology, Inc. A Next-Generation Precision Oncology Company Enabling Smarter And Earlier Cancer Treatment, Today Announced Expansion Of Its Clinical Collaboration With Pfizer In The Strata Precision Indications For Approved Therapies (Strata Pathtm) Trial. Strata Path Is A Prospective Pan-Tumor Therapeutic Trial Designed To Evaluate The Efficacy And Safety Of Multiple Fda-Approved Cancer Therapies In New, Biomarker-Guided Patient Populations. Pfizer Will Provide Braftovi
